TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Photocure ASA ( (PHCUF) ) is now available.
Photocure ASA is set to release its first-quarter financial results for 2025 on May 8th, with a live webcast presentation scheduled for the same day. This announcement is crucial for stakeholders as it provides insights into the company’s financial health and strategic direction, potentially impacting its market position and investor confidence.
More about Photocure ASA
Photocure ASA, known as The Bladder Cancer Company, specializes in delivering innovative solutions for bladder cancer treatment. Their proprietary technology, which highlights cancer cells in bright pink, has significantly improved patient outcomes globally. The company is based in Oslo, Norway, and is publicly traded on the Oslo Stock Exchange.
YTD Price Performance: -18.80%
Average Trading Volume: 953
Technical Sentiment Signal: Buy
Current Market Cap: $142.6M
For an in-depth examination of PHCUF stock, go to TipRanks’ Stock Analysis page.